Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%-.--%-8.63x4.02x3.8x-7.02x-6.59x 2.15B
0.6%0.68%16.94x1.97x3.69x9.97x10.92x 66.56B
0.55%0.57%28.53x4.29x5.87x17.23x21.78x 57.64B
-.--%-.--%34.88x7x11.82x22.38x26.3x 42.24B
3.49%3.58%-43.93x2.4x3.11x9.2x10.74x 39.09B
-.--%-.--%34.9x1.72x3.71x11.39x13.26x 31.91B
-.--%-.--%-9.24x5.42x13.4x-8.22x-7.78x 31.65B
-.--%-.--%16.96x3.4x3.25x9.83x9.74x 23.35B
-.--%0.05%53.7x5.43x5.97x40.99x38.22x 18.92B
-.--%-.--%26.89x3.78x5.5x14.75x20.45x 17.17B
-.--%-.--%-35.48x-6.16x16.45x-50.02x-51.98x 15.12B
-.--%-.--%-123.95x12940.15x12.65x-112.04x-123.11x 12.57B
0.15%0.15%64.31x26.22x39.1x55.3x57.03x 12.22B
-.--%-.--%16.75x - 3.57x13.08x15.68x 11.4B
-.--%-.--%48.65x - - - - 11.06B
2.8%3.24%11.98x1.04x1.81x7.3x9.78x 6.27B
1.56%1.73%14.43x1.33x2.56x6.62x8.02x 5.78B
-.--%-.--%-106.91x - - - - 5.24B
Average 0.51% 0.56% 2.26x 866.80x 8.52x 2.55x 3.28x 22.8B
Weighted average by Cap. 0.58% 0.61% 10.29x 429.06x 7.59x 7.75x 9.21x
Biopharmaceuticals